home / stock / blco / blco news


BLCO News and Press, Bausch + Lomb Corporation From 02/18/26

Stock Information

Company Name: Bausch + Lomb Corporation
Stock Symbol: BLCO
Market: NYSE
Website: bausch.com

Menu

BLCO BLCO Quote BLCO Short BLCO News BLCO Articles BLCO Message Board
Get BLCO Alerts

News, Short Squeeze, Breakout and More Instantly...

BLCO - Bausch + Lomb reports mixed results; initiates FY26outlook

2026-02-18 07:01:55 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bausch + Lomb: I ...

BLCO - Expected US Company Earnings on Wednesday, February 18th, 2026

OGE Energy Corp (OGE) is expected to report $0.3 for Q4 2025 Dana Incorporated (DAN) is expected to report $0.32 for Q4 2025 SiriusPoint Ltd. (SPNT) is expected to report $0.54 for Q4 2025 Nutrien Ltd. (NTR) is expected to report $0.82 for Q4 2025 Broadstone Net Lease Inc. (BNL) i...

BLCO - Moderating Growth Could Be A Tough Challenge For Cooper Shares

2026-02-13 07:42:57 ET The Cooper Companies ( COO ) (“Cooper”) is a case in point as to how you can, like, even admire, a company and yet not have particularly bullish feelings about the stock. Over the years, management has done a good job of leveraging product develo...

BLCO - BLCO Price Target Alert: $21.00. Issued by RBC Capital

2026-01-27 08:19:43 ET from RBC Capital issued a price target of $21.00 for BLCO on 2026-01-27 12:53:46. The adjusted price target was set to $21.00. At the time of the announcement, BLCO was trading at $16.87. The overall price target consensus is at $18.63 with high pr...

BLCO - Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2025 financial results on Wednesday, Feb. 18, 2026. The company will host a conference call and live webcast at 8 a....

BLCO - Bausch Health sets 2025 outlook at the higher end of the prior range

2026-01-13 10:54:37 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path Why Bausch Health Is A Buy After Rising 10% On ...

BLCO - Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12 18:06:02 ET Bausch + Lomb Corporation (BLCO) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthca...

BLCO - Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + Lomb will also sponsor The Glaucoma Foundation’s annual month-long educational social med...

BLCO - Bausch + Lomb completes refinancing of outstanding term B loans

2026-01-02 16:52:07 ET More on Bausch + Lomb, Bausch Health Companies Bausch + Lomb: I Need To See Stability Before Upgrading This Name Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript Bau...

BLCO - Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it closed the previously announced credit agreement refinancing. In connec...

Previous 10 Next 10